Migraine relief may sharpen the mind: study investigates cognitive benefits of preventive therapies

NCT ID NCT07691164

Not yet recruiting Knowledge-focused Sponsor: University Hospital, Strasbourg, France Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study follows adults with severe, treatment-resistant migraines to see if preventive treatments—like Botox injections or Eptinezumab infusions—improve not only headache frequency but also cognitive skills such as attention and memory. Researchers will assess participants' thinking abilities and quality of life over one year. The goal is to understand whether reducing migraines can also help the brain work better.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Botulinum toxin type A (Botox) or Eptinezumab
What this could lead to: If successful, this study could show that treating migraines not only reduces headache frequency but also improves thinking, memory, and daily life.
What could go wrong: This is an observational study with no control group, so improvements could be due to other factors. Results may not apply to all migraine patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC MIGRAINE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

migraine disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC MIGRAINE

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.